Intrinsic Value of S&P & Nasdaq Contact Us

Praxis Precision Medicines, Inc. PRAX NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
62/100
3/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$510.40
+48.5%

Stock Statistics — PRAX

Praxis Precision Medicines, Inc. (PRAX) has a market capitalization of $7.26B and trades at $343.60. The 52-week range is 26.7-356.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -25.5, Earnings Per Share (EPS) of $-13.48.

The stock has a beta of 2.97, operates in the Healthcare sector.

Trading Data
Current Price$343.60
52-Week Range26.7-356
Volume684.25K
Avg Volume (30D)452.09K
Market Cap$7.26B
Beta (1Y)2.97
Company
IPO Date2020-10-16
Employees116
CEOMarcio Silva De'Souza
CountryUS
ExchangeNASDAQ Global Select
CurrencyUSD
ISINUS74006W2070
CUSIP74006W108
Income (Latest Year)
Gross Profit$-140K
EBITDA$-303.13M
Operating Income$-326.2M
Net Income$-303.27M
EPS$-13.48
EPS Diluted$-13.48
Shares Outstanding$22.5M
Balance Sheet (Latest Year)
Total Assets$937.91M
Current Assets$610.91M
Cash & ST Investments$599.33M
Total Liabilities$59.77M
Total Debt$110K
Net Debt$-357.22M
Total Equity$878.14M
Debt / Equity0.00
Valuation Ratios
P/E Ratio-25.5
P/B Ratio8.27
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message